Tag Archives: endocrinology

Many hospitals now treat surgery as more than a single procedure. Increasingly, it has become an opportunity to uncover hidden health conditions that may otherwise go undetected for years. One important trend is perioperative diabetes screening, which helps health systems identify patients with undiagnosed diabetes and prediabetes before surgery begins. …

More adults living with type 1 diabetes are now developing obesity, insulin resistance, hypertension, and metabolic complications once linked mainly to type 2 diabetes. This growing overlap, often called double diabetes, is becoming a major concern for clinicians and patients alike. While insulin therapy remains essential for type 1 diabetes …

The conversation around DIY diabetes technology and patient-led insulin automation has changed dramatically over the past few years. What once existed on the margins of diabetes care is now gaining recognition from major medical organizations and healthcare providers. In fact, the 2026 American Diabetes Association (ADA) Standards of Care continue …

The management of type 1 diabetes during pregnancy is entering a major turning point. For years, endocrinologists and maternal-fetal medicine specialists have worked within narrow therapeutic margins to reduce maternal and neonatal complications. However, new advances in automated insulin delivery technology for pregnancy are beginning to reshape glucose management in …

Automated insulin delivery for people with type 2 diabetes is entering a new phase. What once seemed reserved for highly specialized endocrinology clinics is now moving steadily into primary care offices across the country. Following the updated 2026 American Diabetes Association Standards of Care and recent FDA clearances, more adults …

A glucose alarm goes off during dinner. Another alert appears at 2 a.m. A smartphone app flashes warnings about rising blood sugar before the day even starts. Diabetes technology promises better control, yet for some patients, the nonstop stream of notifications and health data can feel mentally exhausting. Clinicians are …

Screening for fatty liver disease in patients with diabetes is no longer limited to identifying elevated liver enzymes or calculating a fibrosis score during an annual visit. Instead, clinicians are entering an era where diabetes care and hepatology increasingly overlap, especially as metabolic dysfunction-associated steatotic liver disease, or MASLD, becomes …

Cancer treatment is evolving rapidly, and with that progress comes a new challenge for clinicians managing glucose disorders. As immune checkpoint inhibitors (ICIs) and PI3K inhibitors become more widely used in oncology, therapy-related hyperglycemia is appearing more often in clinical practice. Many patients receiving cancer treatment now face unexpected glucose …

Managing Type 2 diabetes used to follow a relatively predictable path. Clinicians often started with metformin and added medications gradually as glucose control worsened. Today, however, diabetes care looks very different. The number of available therapies has expanded rapidly, and while that growth has improved patient outcomes, it has also …

Diabetes screening has improved over the last two decades, yet many patients still fall through the cracks. While clinicians often rely on traditional risk models that focus on obesity, age, family history, and sedentary lifestyle, not every patient with diabetes fits that familiar picture. As a result, many diabetes cases …